Robert Grossman to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Robert Grossman has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.010
-
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol. 1998 Apr; 43(4):499-506.
Score: 0.010